Global X HealthTech ETF $HEAL Shares Purchased by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors boosted its holdings in Global X HealthTech ETF (NASDAQ:HEAL) by 28.3% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 195,122 shares of the company’s stock after purchasing an additional 43,075 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors owned 0.19% of Global X HealthTech ETF worth $5,758,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Royal Bank of Canada lifted its holdings in shares of Global X HealthTech ETF by 39.4% during the first quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock worth $62,000 after buying an additional 736 shares during the last quarter. Farther Finance Advisors LLC boosted its position in shares of Global X HealthTech ETF by 4.3% in the third quarter. Farther Finance Advisors LLC now owns 23,037 shares of the company’s stock valued at $680,000 after acquiring an additional 950 shares during the period. Finally, WT Wealth Management grew its stake in shares of Global X HealthTech ETF by 14.7% in the first quarter. WT Wealth Management now owns 101,116 shares of the company’s stock worth $2,409,000 after acquiring an additional 12,945 shares during the last quarter.

Global X HealthTech ETF Trading Down 1.0%

Shares of Global X HealthTech ETF stock opened at $29.51 on Thursday. Global X HealthTech ETF has a 1 year low of $23.00 and a 1 year high of $33.30. The company’s fifty day simple moving average is $29.29 and its 200-day simple moving average is $27.14. The company has a market cap of $30.99 million, a price-to-earnings ratio of 42.80 and a beta of 1.13.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.